Rubinstein-Taybi syndrome

Jump to: navigation, search
Rubinstein-Taybi syndrome
ICD-10 Q87.2
ICD-9 759.89
OMIM 180849
DiseasesDB 29344
eMedicine derm/711  ped/2026
MeSH D012415

WikiDoc Resources for Rubinstein-Taybi syndrome

Articles

Most recent articles on Rubinstein-Taybi syndrome

Most cited articles on Rubinstein-Taybi syndrome

Review articles on Rubinstein-Taybi syndrome

Articles on Rubinstein-Taybi syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Rubinstein-Taybi syndrome

Images of Rubinstein-Taybi syndrome

Photos of Rubinstein-Taybi syndrome

Podcasts & MP3s on Rubinstein-Taybi syndrome

Videos on Rubinstein-Taybi syndrome

Evidence Based Medicine

Cochrane Collaboration on Rubinstein-Taybi syndrome

Bandolier on Rubinstein-Taybi syndrome

TRIP on Rubinstein-Taybi syndrome

Clinical Trials

Ongoing Trials on Rubinstein-Taybi syndrome at Clinical Trials.gov

Trial results on Rubinstein-Taybi syndrome

Clinical Trials on Rubinstein-Taybi syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Rubinstein-Taybi syndrome

NICE Guidance on Rubinstein-Taybi syndrome

NHS PRODIGY Guidance

FDA on Rubinstein-Taybi syndrome

CDC on Rubinstein-Taybi syndrome

Books

Books on Rubinstein-Taybi syndrome

News

Rubinstein-Taybi syndrome in the news

Be alerted to news on Rubinstein-Taybi syndrome

News trends on Rubinstein-Taybi syndrome

Commentary

Blogs on Rubinstein-Taybi syndrome

Definitions

Definitions of Rubinstein-Taybi syndrome

Patient Resources / Community

Patient resources on Rubinstein-Taybi syndrome

Discussion groups on Rubinstein-Taybi syndrome

Patient Handouts on Rubinstein-Taybi syndrome

Directions to Hospitals Treating Rubinstein-Taybi syndrome

Risk calculators and risk factors for Rubinstein-Taybi syndrome

Healthcare Provider Resources

Symptoms of Rubinstein-Taybi syndrome

Causes & Risk Factors for Rubinstein-Taybi syndrome

Diagnostic studies for Rubinstein-Taybi syndrome

Treatment of Rubinstein-Taybi syndrome

Continuing Medical Education (CME)

CME Programs on Rubinstein-Taybi syndrome

International

Rubinstein-Taybi syndrome en Espanol

Rubinstein-Taybi syndrome en Francais

Business

Rubinstein-Taybi syndrome in the Marketplace

Patents on Rubinstein-Taybi syndrome

Experimental / Informatics

List of terms related to Rubinstein-Taybi syndrome


Rubinstein-Taybi syndrome (also known as Broad Thumb-Hallux syndrome) is a condition characterized by short stature, moderate to severe mental retardation, distinctive facial features, and broad thumbs and first toes. Other features of the disorder vary among affected individuals. People with this condition have an increased risk of developing noncancerous and cancerous tumors, leukemia, and lymphoma. This condition is inherited in an autosomal dominant pattern and is uncommon occurring in an estimated 1 in 125,000 births.

Features of Rubinstein-Taybi syndrome

An isolated case was described in 1957 by Michail and Matsoukas. In 1963 Rubinstein and Taybi described a larger series of cases. Typical features of the disorder include:

  • Broad thumbs and broad first toes
  • Mental disability
  • Small height, bone growth, small head
  • Cryptorchidism in males
  • Unusual faces - eyes, nose, palate

1 out of 300,000 children are born with RTS

Genetics

Rubinstein-Taybi syndrome is inherited in an autosomal dominant fashion.

Mutations in the CREBBP gene cause Rubinstein-Taybi syndrome. The CREBBP gene makes a protein that helps control the activity of many other genes. The protein, called CREB binding protein, plays an important role in regulating cell growth and division and is essential for normal fetal development. If one copy of the CREBBP gene is deleted or mutated, cells make only half of the normal amount of CREB binding protein. A reduction in the amount of this protein disrupts normal development before and after birth, leading to the signs and symptoms of Rubinstein-Taybi syndrome.

Mutations in the EP300 gene are responsible for a small percentage of cases of Rubinstein-Taybi syndrome. These mutations result in the loss of one copy of the gene in each cell, which reduces the amount of p300 protein by half. Some mutations lead to the production of a very short, nonfunctional version of the p300 protein, while others prevent one copy of the gene from making any protein at all. Although researchers do not know how a reduction in the amount of p300 protein leads to the specific features of Rubinstein-Taybi syndrome, it is clear that the loss of one copy of the EP300 gene disrupts normal development.

References

  • Coupry I, Monnet L, Attia AA, Taine L, Lacombe D, Arveiler B (2004). "Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR". Human mutation. 23 (3): 278–84. PMID 14974086. Unknown parameter |month= ignored (help)
  • Michail J, Matsoukas J, Theodorou S (1957). "[Arched, clubbed thumb in strong abduction-extension & other concomitant symptoms]". Revue de chirurgie orthopédique et réparatrice de l'appareil moteur. 43 (2): 142–6. PMID 13466652. Unknown parameter |month= ignored (help)
  • Rubinstein JH, Taybi H (1963). "Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome". American journal of diseases of children. 105: 588–608. PMID 13983033. Unknown parameter |month= ignored (help)

External links


de:Rubinstein-Taybi-Syndrom



Linked-in.jpg